I posted this on the other board. I will post her
Post# of 148292
(Total Views: 325)
Posted On: 04/11/2019 11:04:53 AM
Re: DoubleBagger24 #1903
I posted this on the other board. I will post here for those that don't see it about Paulson and the AS.
Quote: More dilution is on the way before a licensing deal is made.
Good post (I didn't quote the full post). We will see about this last statement. From the 10Q they are still working on licensing PCa test with an interested party and also (HIV region specific). They raised $4.4M last week and $3M a couple weeks before that. The vote is 6 weeks away, over which time we should learn a lot more information and that $4.4M cash matches exactly with one month burn rate in Q1, which could drop more in Q2 (as low as $3.5M per month), down from $5.5M per month burn in Q4 as noted in the 10Q because of less needed for CMO now. It is possible that $4.4M last week was the end of paulson, because they could get the deal done over the next 6 weeks, but they definitively need to show and have a backup if the deal does not go through. Even then I would not expect the big $30M cash raises of the past needed for the BLA, probably more like the last two months until the get more cancer data, complete bla filing, mono pivotal trial, etc, to ignite the share price first. JMO.
Quote: More dilution is on the way before a licensing deal is made.
Good post (I didn't quote the full post). We will see about this last statement. From the 10Q they are still working on licensing PCa test with an interested party and also (HIV region specific). They raised $4.4M last week and $3M a couple weeks before that. The vote is 6 weeks away, over which time we should learn a lot more information and that $4.4M cash matches exactly with one month burn rate in Q1, which could drop more in Q2 (as low as $3.5M per month), down from $5.5M per month burn in Q4 as noted in the 10Q because of less needed for CMO now. It is possible that $4.4M last week was the end of paulson, because they could get the deal done over the next 6 weeks, but they definitively need to show and have a backup if the deal does not go through. Even then I would not expect the big $30M cash raises of the past needed for the BLA, probably more like the last two months until the get more cancer data, complete bla filing, mono pivotal trial, etc, to ignite the share price first. JMO.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼